A Mouse Model for Chikungunya: Young Age and Inefficient Type-I Interferon Signaling Are Risk Factors for Severe Disease

Archive ouverte

Couderc, Thérèse | Chrétien, Fabrice | Schilte, Clémentine | Disson, Olivier | Brigitte, Madly | Guivel-Benhassine, Florence | Touret, Yasmina | Barau, Georges | Cayet, Nadège | Schuffenecker, Isabelle | Desprès, Philippe | Arenzana-Seisdedos, Fernando | Michault, Alain | Albert, Matthew L. | Lecuit, Marc

Edité par CCSD ; Public Library of Science -

International audience. Chikungunya virus (CHIKV) is a re-emerging arbovirus responsible for a massive outbreak currently afflicting the Indian Ocean region and India. Infection from CHIKV typically induces a mild disease in humans, characterized by fever, myalgia, arthralgia, and rash. Cases of severe CHIKV infection involving the central nervous system (CNS) have recently been described in neonates as well as in adults with underlying conditions. The pathophysiology of CHIKV infection and the basis for disease severity are unknown. To address these critical issues, we have developed an animal model of CHIKV infection. We show here that whereas wild type (WT) adult mice are resistant to CHIKV infection, WT mouse neonates are susceptible and neonatal disease severity is age-dependent. Adult mice with a partially (IFN-alpha/betaR(+/-)) or totally (IFN-alpha/betaR(-/-)) abrogated type-I IFN pathway develop a mild or severe infection, respectively. In mice with a mild infection, after a burst of viral replication in the liver, CHIKV primarily targets muscle, joint, and skin fibroblasts, a cell and tissue tropism similar to that observed in biopsy samples of CHIKV-infected humans. In case of severe infections, CHIKV also disseminates to other tissues including the CNS, where it specifically targets the choroid plexuses and the leptomeninges. Together, these data indicate that CHIKV-associated symptoms match viral tissue and cell tropisms, and demonstrate that the fibroblast is a predominant target cell of CHIKV. These data also identify the neonatal phase and inefficient type-I IFN signaling as risk factors for severe CHIKV-associated disease. The development of a permissive small animal model will expedite the testing of future vaccines and therapeutic candidates.

Suggestions

Du même auteur

Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion.

Archive ouverte | Gérardin, Patrick | CCSD

International audience. BACKGROUND: An outbreak of chikungunya virus affected over one-third of the population of La Réunion Island between March 2005 and December 2006. In June 2005, we identified the first case of...

Characterization of reemerging chikungunya virus.

Archive ouverte | Sourisseau, Marion | CCSD

International audience. An unprecedented epidemic of chikungunya virus (CHIKV) infection recently started in countries of the Indian Ocean area, causing an acute and painful syndrome with strong fever, asthenia, ski...

Type I IFN controls chikungunya virus via its action on nonhematopoietic cells.

Archive ouverte | Schilte, Clémentine | CCSD

International audience. Chikungunya virus (CHIKV) is the causative agent of an outbreak that began in La Réunion in 2005 and remains a major public health concern in India, Southeast Asia, and southern Europe. CHIKV...

Chargement des enrichissements...